We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Sun Pharma Advanced Research Company (SPARC) announced the top-line results of the Phase III efficacy study and duration of action study for Baclofen GRS.